Date Title Description PDF
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download

Pages

Date Title Description PDF
23 Feb 2022 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2021 annual report regarding remuneration of the members of the Board of Directors Download
23 Feb 2022 Annual Corporate Governance Report ROVI releases the 2021 Annual Corporate Governance Report Download
21 Feb 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 14 February 2022 and 21 February 2022 Download
15 Feb 2022 On business and financial situation ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone. Download
14 Feb 2022 Share buy-back , stabilisation and treasury stock programme Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022 Download

Pages

Date Title Description PDF
06 Nov 2018 Información sobre resultados ROVI releases the presentation related to the nine-month period ended 30 September 2018 results. Download
06 Nov 2018 Información sobre resultados ROVI releases the press release related to the nine-month period ended 30 September 2018 results. Download
17 Oct 2018 Buy-back programmes, stabilisation and treasury stock ROVI informs of the resumption of operations with own shares under the liquidity contract Download
17 Oct 2018 Buy-back programmes, stabilisation and treasury stock ROVI informs that Jefferies International Limited has exercised, in full, the greenshoe subscription option Download
08 Oct 2018 Share capital increases and reductions Information on new shares admissions related to the capital increase of ROVI Download

Pages